- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.06. | CVRx, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22.05. | CVRx, Inc.: CVRx to Present at the William Blair 44th Annual Growth Stock Conference | 1 | GlobeNewswire (USA) | ||
| 16.05. | CVRx, Inc.: CVRx Announces Key Senior Leadership Team Hires | 1 | GlobeNewswire (USA) | ||
| 15.05. | CVRx bolsters its executive ranks with hires from Abbott, Medtronic | 6 | MassDevice | ||
| 01.05. | Pre-market Movers: IM Cannabis, CVRx, TG Therapeutics, Root, Inc., Plutonian Acquisition/Big Tree Cloud | 367 | AFX News | WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86.
TG... ► Artikel lesen | |
| 01.05. | Why Is CVRx (CVRX) Stock Down 32% Today? | 3 | InvestorPlace | ||
| 01.05. | Earnings call: CVRx reports revenue growth despite sales disruptions | 2 | Investing.com | ||
| 01.05. | CVRx GAAP EPS of -$1.04 misses by $0.50, revenue of $10.8M misses by $0.57M | 2 | Seeking Alpha | ||
| 30.04. | CVRx, Inc.: CVRx Reports First Quarter 2024 Financial and Operating Results | 61 | GlobeNewswire (Europe) | MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| 19.04. | CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits | 1 | Zacks | ||
| 16.04. | CVRx, Inc.: CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 | 1 | GlobeNewswire (USA) | ||
| 16.04. | CVRx has more data supporting long-term benefits of Barostim | 1 | MassDevice | ||
| 15.04. | CVRx, Inc.: CVRx announces availability of additional data supporting long-term benefits of Barostim | 1 | GlobeNewswire (USA) | ||
| 09.02. | CVRx, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 31.01. | Augmedics CEO takes over corner office at CVRx | 2 | MassDevice | ||
| 31.01. | CVRx, Inc.: CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer | 295 | GlobeNewswire (Europe) | Appointment effective February 12 following Nadim Yared's retirement Hykes currently serves as Augmedics' President and CEO, and has served on CVRx's Board of Directors since 2022 MINNEAPOLIS, Jan.... ► Artikel lesen | |
| 27.01. | CVRx, Inc. (CVRX) Q4 2023 Earnings Call Transcript | 3 | Insider Monkey | ||
| 26.01. | CVRx stock dips despite Street-beating Q4 | 1 | MassDevice | ||
| 26.01. | Analyst Expectations For CVRx's Future | 3 | Benzinga.com | ||
| 25.01. | CVRx Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters |
Seite:
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 11,128 | -1,92 % | ORPEA: emeis Sells a Real-Estate Portfolio of Three Nursing Homes in Ireland Worth a Total Value of Around €56 Million | Regulatory News:
emeis (Paris:ORP) announces that it has signed a sale and lease back agreement on a real estate portfolio of three nursing homes in Ireland with Healthcare Activos for a purchase... ► Artikel lesen | |
| NANO-X IMAGING | 7,240 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 0,875 | 0,00 % | Butterfly Network, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| CARMAT | 2,290 | +4,57 % | CARMAT Announces the Start of the Equitization of the First Tranche of Its EIB Loan | Equitization of the first tranche of the EIB loan will reduce its repayment in cash and optimize the Company's cash position Set-up of a trust and issuance of share warrants to the trustee... ► Artikel lesen | |
| GOODRX | 8,155 | -2,80 % | GoodRx Reports First Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading destination for prescription savings in the U.S., has released... ► Artikel lesen | |
| JOINT CORP | 13,960 | +2,05 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
| HYPERFINE | 0,832 | 0,00 % | Hyperfine, Inc. - 8-K, Current Report | ||
| PROGYNY | 25,730 | 0,00 % | Pre-market Movers: Novavax, MacroGenics, AEye, Sensus Healthcare, Progyny | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.10 A.M. ET).In the Green Novavax, Inc. (NVAX) is up over 108% at $9.30.
AEye... ► Artikel lesen | |
| OUTSET MEDICAL | 3,640 | 0,00 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| BIOMERICA | 0,583 | 0,00 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| MIMEDX | 6,910 | +0,58 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| ATRICURE | 21,160 | +6,55 % | AtriCure gains amid report of Edwards Lifesciences interest | ||
| ATRION | 422,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,240 | -1,75 % | Talkspace to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit | ||
| PROCEPT BIOROBOTICS | 62,03 | 0,00 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen |
CVRX INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 11,050 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
